Brunelli G, Vigasio A, Mukenge S, Verdecchia P
Int Surg. 1982 Apr-Jun;67(2):163-8.
To evaluate the antithrombotic effect of sulfinpyrazone on blood vessels (1-2 mm diameter) injured by microsurgical procedures, twenty male rabbits were chosen at random to receive sulfinpyrazone (10 mg/kg/die) or placebo three days prior to and on the morning of vascular microsurgery, which consisted of a complete transverse section, or a longitudinal section 1 cm long, of the femoral artery and vein, followed by interrupted suture. Scanning electron microscopy revealed consistently less fibrin and blood cell adhesion to the endothelial areas adjacent to the surgical trauma in the animals treated with sulfinpyrazone than in those treated with placebo. Our results agree with those reported in the literature, demonstrating the antithrombotic effects of sulfinpyrazone at the level of the vascular endothelium injured by various kinds of trauma and are sufficiently encouraging to justify testing this drug in the prevention of vascular thrombosis following microsurgical procedures in man.
为评估磺吡酮对显微外科手术损伤血管(直径1 - 2毫米)的抗血栓形成作用,随机选取20只雄性兔子,在血管显微手术前三天及手术当天早晨给予磺吡酮(10毫克/千克/日)或安慰剂。血管显微手术包括对股动脉和静脉进行完全横断或1厘米长的纵切,随后间断缝合。扫描电子显微镜显示,与接受安慰剂治疗的动物相比,接受磺吡酮治疗的动物手术创伤附近内皮区域的纤维蛋白和血细胞黏附始终较少。我们的结果与文献报道一致,表明磺吡酮在各种创伤损伤的血管内皮水平具有抗血栓形成作用,足以令人鼓舞,值得在人体显微外科手术后预防血管血栓形成中测试该药物。